Abstract
Background Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterised by cognitive decline, memory loss, and impaired daily functioning. As the global population ages, the prevalence of AD continues to rise, emphasising the urgent need for effective preventive and therapeutic strategies. Carotenoids, a group of naturally occurring pigments with antioxidant properties, have gained attention for their potential neuroprotective effects. Carotenoids interrupt the oxidative process by scavenging free radicals and quenching singlet oxygen, ultimately reducing lipid oxidation and preserving the integrity of lipids in biological systems. This project investigated the relationship between blood carotenoid levels, lipid oxidation and their impact on cognitive impairment.
| Original language | English |
|---|---|
| Number of pages | 2 |
| Journal | Alzheimer's & Dementia |
| Volume | 20 |
| Issue number | S2 |
| Early online date | 9 Jan 2025 |
| DOIs | |
| Publication status | Published - 9 Jan 2025 |
Bibliographical note
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, providedthe original work is properly cited.
© 2024 The Alzheimer’s Association. Alzheimer’s & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer’s Association